Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal product.

MLA

Bibby, Anna C., et al. “Commentary: Considerations for Using the ‘Trials within Cohorts’ Design in a Clinical Trial of an Investigational Medicinal Product.” Trials, vol. 19, no. 1, Jan. 2018, p. 18. EBSCOhost, https://doi.org/10.1186/s13063-017-2432-3.

APA

Bibby, A. C., Torgerson, D. J., Leach, S., Lewis-White, H., & Maskell, N. A. (2018). Commentary: considerations for using the “Trials within Cohorts” design in a clinical trial of an investigational medicinal product. Trials, 19(1), 18. https://doi.org/10.1186/s13063-017-2432-3

Chicago

Bibby, Anna C, David J Torgerson, Samantha Leach, Helen Lewis-White, and Nick A Maskell. 2018. “Commentary: Considerations for Using the ‘Trials within Cohorts’ Design in a Clinical Trial of an Investigational Medicinal Product.” Trials 19 (1): 18. doi:10.1186/s13063-017-2432-3.